NCT02391623 - A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Healthy Subjects

Interventions

DRUG

PF-06427878

PF-06427878 will be administered as an extemporaneously prepared solution every 8 hours for 14 days (n=8).

DRUG

Placebo

Placebo will be administered as an extemporaneously prepared solution every 8 hours for 14 days (n=2).

DRUG

PF-06427878

PF-06427878 will be administered as an extemporaneously prepared solution every 12 hours for 14 days (n=8).

DRUG

Placebo

Placebo will be administered as an extemporaneously prepared solution every 12 hours for 14 days (n=2).

Trial Locations (1)

Pfizer Clinical Research Unit, Brussels